Rizatriptan Benzoate recalls

Rizatriptan Benzoate products have been recalled 4 times, most recently on 23 Jul 2025. The recalling company is usually Ascend Laboratories. The most common reason is potency & assay.

Total recalls4since 2021

Last 12 months0reported

Class I00% of total

Ongoing2latest 23 Jul 2025

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 2 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 2 50%Class III 2 50%

Why rizatriptan benzoate is recalled

Potency & Assay250%
Nitrosamine Impurity250%

Companies

Ascend Laboratories250%
Macleods Pharma USA250%

By year

2025250%
2021250%

Ongoing rizatriptan benzoate recalls

2 active

Reported	Class	Recall	Company	Reason	Where
23 Jul 2025Drug	CLASS II	Rizatriptan Benzoate Tablets recalled by Ascend LaboratoriesRizatriptan Benzoate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
23 Jul 2025Drug	CLASS II	Rizatriptan Benzoate Tablets recalled by Ascend LaboratoriesRizatriptan Benzoate	Ascend Laboratories	Nitrosamine Impurity	Nationwide

All rizatriptan benzoate recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
23 Jul 2025Drug	CLASS II	Rizatriptan Benzoate Tablets recalled by Ascend LaboratoriesRizatriptan Benzoate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
23 Jul 2025Drug	CLASS II	Rizatriptan Benzoate Tablets recalled by Ascend LaboratoriesRizatriptan Benzoate	Ascend Laboratories	Nitrosamine Impurity	Nationwide
3 Nov 2021Drug	CLASS III	Rizatriptan Benzoate Orally Disintegrating Tablets 5mg recalledRizatriptan Benzoate	Macleods Pharma USA	Potency & Assay	Nationwide
3 Nov 2021Drug	CLASS III	Rizatriptan Benzoate Orally Disintegrating Tablets 10mg recalledRizatriptan Benzoate	Macleods Pharma USA	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.